Dr. Shaun P. McKenzie is board certified in general surgery and in surgical oncology, hepatobiliary surgery, and pancreatic surgery. He is a surgical oncologist with Texas Oncology Surgical ...

Researchers at Tezpur University in India have identified a panel of circulating microRNAs in blood serum that may help distinguish gallbladder cancer from benign conditions, offering a potential ...

Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get ...

This post details the symptoms and treatment of bile duct cancer, a rare and dangerous form of cancer. Bile duct cancer is a rare cancer that forms in the bile ducts, which carry bile from the liver ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to zanidatamab-hrii for treatment of adults with previously treated ...

Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...

Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options ...

TAMARA Mulley was stuck on an NHS waitlist for a hospital referral for nearly a year, after visiting her GP with bloating and hip pain. When the appointment rolled around, she was given two years ...

When do you have tests for bile duct cancer? Bile duct cancer is also called cholangiocarcinoma. It is a rare type of cancer that develops in the bile ducts. Most people are diagnosed with bile duct ...

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology showed that chemotherapy combining three different ...